XRCC5 and neoplasm: In the nude mouse model, compared with the control group, intratumor injection of cholesterol-conjugated Ku80 siRNA inhibited Ku80 expression and significantly suppressed subcutaneous tumor growth (P<0.05; Figures 5e and f).